UK HealthCare

Kuhs Named Co-Leader of Markey Cancer Prevention & Control Research Program

Krystle Kuhs
Krystle Kuhs will co-lead the Markey Cancer Prevention and Control Research Program alongside Jerod Stapleton and will serve as as an associate professor in the UK College of Public Health's Department of Epidemiology.

LEXINGTON, Ky. (Aug. 4, 2020) – The University of Kentucky Markey Cancer Center has announced that Krystle Kuhs, Ph.D., M.P.H., will serve as co-leader of its Cancer Prevention and Control Research Program. Kuhs will co-lead the program with University of Kentucky College of Public Health Associate Professor Jerod Stapleton, Ph.D., who joined the university in November 2019. In addition to her role at Markey, Kuhs will serve in the UK College of Public Health as an associate professor in the Department of Epidemiology.  

The Markey Cancer Prevention and Control Research Program examines and addresses factors associated with Kentucky’s excessively high cancer incidence and mortality rates, with a focus on the state’s rural and Appalachian populations. As a cancer prevention researcher trained in both basic laboratory science and epidemiology, Kuhs’ experience allows her to apply basic science findings to population-based studies, which will be essential to lowering cancer rates in the hardest-hit areas of the state.

“I am very excited to be joining the Markey Cancer Center, an institution with an incredibly strong commitment to cancer prevention,” Kuhs said. “I look forward to working with Dr. Stapleton and program members to further grow this important area of research.” 

Prior to coming to UK, Kuhs served as an assistant professor in Vanderbilt University Medical Center’s Department of Medicine. She earned her doctorate degree in biomedical sciences/pharmacology from the University of Pennsylvania in 2011 and completed a master’s degree in public health from the Johns Hopkins Bloomberg School of Public Health in 2012. In 2016, she completed a Cancer Prevention Postdoctoral Fellowship with the National Cancer Institute.

Her research focuses on developing novel molecular predictors of head and neck cancer risk, response to treatment and risk of recurrence, with a particular focus on head and neck cancers caused by HPV. 

The University of Kentucky is increasingly the first choice for students, faculty and staff to pursue their passions and their professional goals. In the last two years, Forbes has named UK among the best employers for diversity, and INSIGHT into Diversity recognized us as a Diversity Champion three years running. UK is ranked among the top 30 campuses in the nation for LGBTQ* inclusion and safety. UK has been judged a “Great College to Work for" three years in a row, and UK is among only 22 universities in the country on Forbes' list of "America's Best Employers."  We are ranked among the top 10 percent of public institutions for research expenditures — a tangible symbol of our breadth and depth as a university focused on discovery that changes lives and communities. And our patients know and appreciate the fact that UK HealthCare has been named the state’s top hospital for four straight years. Accolades and honors are great. But they are more important for what they represent: the idea that creating a community of belonging and commitment to excellence is how we honor our mission to be not simply the University of Kentucky, but the University for Kentucky.